Lung cancer is a deadly form of cancer and is responsible for many deaths worldwide. More than two million cases of lung cancer are diagnosed annually. This increasing incidence of the disease…
Tag: Lung Cancer Awareness
How Lung Cancer Affects Quality of Life
Lung cancer remains the leading cause of cancer-related deaths worldwide. Patients with lung cancer often experience multiple symptoms associated with the disease as well as during the treatment process. The adverse effects…
Lung Cancer Risk Factors in Adults with Interstitial Lung Disease
Interesting Lung Diseases (ILDs) are characterized by pathological changes in Pulmonary parenchyma. It is a group of conditions that cause inflammation in the lungs. This can be caused by medication, radiation therapy…
Cooking Fumes and Lung Cancer – What’s the Association?
Over the past few years, lung cancer no longer remains among men only but is also on the rise among women. This is primarily due to shifts in smoking habits and environmental…
Study: New Nanoparticles Therapy for Lung Cancer Patients
A new research led by Gaurav Sahay of Oregon State University’s College ir Pharmacy was conducted in collaboration with Oregon Health & Science University and the University of Helsinki. In this study,…
Study: Wildfire Smoke Exposure Affects Lung Cancer Survival
Wildfire Smoke is more toxic in comparison with normal air pollution. It contains traces of chemicals, metals and other synthetic materials in addition to soil and biological materials. A California study has…
Predicting Lung Cancer Risk with AI based Deep Learning Model
New research has been presented during the American Thoracic Society 2025 International Conference. This new deep learning model was able to predict lung cancer risk by using low-dose CT screening exam. The…
FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC
The FDA has granted accelerated approval to Telisotuzumab vedotin for the treatment of patients with locally advanced or metastatic, nonsquamous non-small cell lung cancer with high c-MET protein overexpression. This approval is…